From October 1, 2023 to December 31, 2023, the company has repurchased 932,000 shares, representing 0.47% for CNY 10.08 million. With this, the company has completed the repurchase of 1,105,000 shares, representing 0.56% for CNY 13.4 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.98 CNY | -0.88% | -5.09% | -21.79% |
1st Jan change | Capi. | |
---|---|---|
-21.79% | 463M | |
+31.84% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.32% | 239B | |
+9.99% | 210B | |
-6.99% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 002940 Stock
- News Zhejiang AngLiKang Pharmaceutical CO.,LTD.
- Tranche Update on Zhejiang AngLiKang Pharmaceutical CO.,LTD.'s Equity Buyback Plan announced on August 31, 2023.